Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500107995Phase 2Not yet recruiting
Phase 2, randomised trial of tegileridine in perioperative pain and procedural pain (4 arms), sponsored by First Affiliated Hospital of Gannan Medical University. Primary endpoint: ED95 of tegileridine fumarate + propofol for hysteroscopic surgery. Planned start Aug 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500107995.